# OnCo record nct06060613 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06060613/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06060613", "NCT06060613" ;
  schema:name "Safety and Efficacy of OBX-115 in Advanced Solid Tumors"@en ;
  schema:alternateName "Agni-01"@en ;
  schema:description "A phase 1/2 trial of OBX-115 in melanoma and non-small-cell lung cancer, run by Obsidian Therapeutics, Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06060613/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06060613> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2023-10-25" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/nsclc/> ;
  onco:companies <https://onco.cc/companies/obsidian-therapeutics/> .